Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)8.98
  • Today's Change-0.03 / -0.33%
  • Shares traded14.64m
  • 1 Year change-59.24%
  • Beta0.6813
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Walgreens Boots Alliance Inc had net income fall from a gain of 4.34bn to a loss of 3.08bn despite a 4.81% increase in revenues from 132.70bn to 139.08bn. An increase in the cost of goods sold as a percentage of sales from 78.70% to 80.56% was a component in the falling net income despite rising revenues.
Gross margin18.35%
Net profit margin-8.66%
Operating margin-8.58%
Return on assets-13.89%
Return on equity-33.49%
Return on investment-20.99%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Walgreens Boots Alliance Inc fell by 1.70bn. However, the company earned 2.26bn from its operations for a Cash Flow Margin of 1.62%. In addition the company used 3.09bn on investing activities and also paid 887.00m in financing cash flows.
Cash flow per share-11.78
Price/Cash flow per share--
Book value per share15.80
Tangible book value per share-17.39
More ▼

Balance sheet in USDView more

Walgreens Boots Alliance Inc has a Debt to Total Capital ratio of 39.09%, a lower figure than the previous year's 46.37%.
Current ratio0.6526
Quick ratio0.3099
Total debt/total equity0.7258
Total debt/total capital0.3909
More ▼

Growth rates in USD

Year on year, growth in dividends per share marginally increased 0.52% while earnings per share excluding extraordinary items fell by -171.24%. Additionally, five year annualized dividend per share growth ranks highest in its industry.
Div yield(5 year avg)4.99%
Div growth rate (5 year)3.71%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-75.56
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.